Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Trial of Intra-pleuraL bacterial immuno-Therapy in mesothelioma (TILT): A feasibility study using the 'trial within a cohort' methodology

Trial Profile

A Trial of Intra-pleuraL bacterial immuno-Therapy in mesothelioma (TILT): A feasibility study using the 'trial within a cohort' methodology

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 08 Jan 2019

At a glance

  • Drugs Picibanil (Primary)
  • Indications Mesothelioma
  • Focus Adverse reactions
  • Acronyms TILT
  • Most Recent Events

    • 06 Jun 2019 Status changed from recruiting to active, no longer recruiting.
    • 06 Jun 2018 Planned number of patients changed from 48 to 24.
    • 12 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top